Back

TRIO score for risk stratification of 12-month mortality after transcatheter tricuspid valve intervention

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Transcatheter tricuspid valve interventions Tricuspid Valve Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Christoph Edlinger

Salzburg university hospital, Salzburg (Austria)

7 More presentations in this session

Presentation thumbnail
Liver extracellular volume improves after transcatheter tricuspid valve intervention: seminal insights from TRILUMINATE Pivotal imaging substudy
Doctor J. Cavalcante (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Feasibility and diagnostic concordance of a transthoracic en face view for tricuspid valve morphological assessment
Doctor R. Lopez Ditch (Ciudad De Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Combined TRI-Score and pulmonary vascular resistance enhance 12-month mortality prediction after transcatheter tricuspid valve intervention
Doctor J. Schlegl (Bernau bei Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Transcatheter tricuspid valve intervention versus medical therapy in severe tricuspid regurgitation: a systematic review and bayesian meta-analysis of randomized controlled trials
Mr L. Rizzolli (Caxias Do Sul, BR)
Abstract Slides Video
Presentation thumbnail
Differential impact of transcatheter tricuspid valve interventions on right heart reverse remodelling: systematic review
Doctor M. Jawed (Dublin, IE)

Access the full session

Session thumbnail
Transcatheter tricuspid valve interventions

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
ESC Journals
TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation
25 August 2023
thumbnail
Congress Presentation
The EPICTER score: a bedside and easy tool to predict mortality at six months in acute heart failure
29 June 2021
thumbnail
Congress Presentation
C-Reactive Protein to Albumin Ratio offers superior risk prediction in patients undergoing mitral valve edge-to-edge repair: a comparison to established surgical risk scores
28 August 2022
thumbnail
Congress Presentation
Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources